FDA Inspection 1321532 — Rhode Island Blood Center, a Division of New York Blood Center, Inc. Aquidneck Island Donor Center

Rhode Island Blood Center, a Division of New York Blood Center, Inc. Aquidneck Island Donor Center — FEI 1000159706

The FDA completed an inspection of Rhode Island Blood Center, a Division of New York Blood Center, Inc. Aquidneck Island Donor Center on May 12, 2026 in Middletown, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 12, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Middletown, RI (United States)